SHAREHOLDER ALERT: Potential Recovery for AlloVir, Inc. (ALVR) Investors
PremiumClass ActionSHAREHOLDER ALERT: Potential Recovery for AlloVir, Inc. (ALVR) Investors
8M ago
AlloVir Faces Delisting Risk, Considers Reverse Split to Comply
Premium
Company Announcements
AlloVir Faces Delisting Risk, Considers Reverse Split to Comply
9M ago
Allovir Inc (ALVR) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Allovir Inc (ALVR) Q4 Earnings Cheat Sheet
9M ago
AlloVir downgraded to Underperform from Buy at BofA
PremiumThe FlyAlloVir downgraded to Underperform from Buy at BofA
11M ago
AlloVir downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
AlloVir downgraded to Equal Weight from Overweight at Morgan Stanley
11M ago
AlloVir downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
AlloVir downgraded to Market Perform from Outperform at Leerink
11M ago
AlloVir to discontinue three global Phase 3 posoleucel studies
PremiumThe FlyAlloVir to discontinue three global Phase 3 posoleucel studies
11M ago
AlloVir reports Q3 EPS (39c), consensus (42c)
Premium
The Fly
AlloVir reports Q3 EPS (39c), consensus (42c)
1y ago
ALVR Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ALVR Upcoming Earnings Report: What to Expect?
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100